The 2001 Bethesda System for reporting cervical or vaginal cytologic diagnoses is an
incremental change in the uniform terminology introduced in 1988 and revised in 1991. The …

The Bethesda System (TBS) for Reporting CervicaVVaginal Cytologic Diagnoses was
developed at a National Cancer Institute (NCI)-sponsored workshop in December 1988 to …

Abstract The Bethesda System for reporting cervical/vaginal diagnoses was introduced to
replace the numerical Papanicolaou class designations, thereby facilitating precise …

The Bethesda (TBS) for reporting cervical/vaginal cytologic diagnoses was developed by a
1988 National Cancer Institute (NCI) workshop convened to consider benefits of increased …

Abstract Context.—The Bethesda System for reporting cervical/vaginal cytologic diagnoses
introduced terminology for atypical squamous and glandular cells and categories for …

Abstract Context.—The 2001 Bethesda System for the reporting of cervical cytology
specimens and the use of new liquid-based and human papillomavirus testing technologies …

The Bethesda System for reporting the results of cervical cytology was developed as a
uniform system of terminology, providing clear guidance for clinical management. The …

OBJECTIVES: To estimate the rates of and identify risk factors for disease in women with
atypical glandular cells of undetermined significance (AGUS). METHODS: From 1998–2001 …

Abstract BACKGROUND. The Bethesda System (TBS) along with its companion atlas was
updated in 2001 to improve standardization, clarity, and reproducibility of cervical cytology …

Objective. The goal of this study was to determine the colposcopic findings underlying
cytologic abnormalities classified according to the Bethesda system. Methods. Women …